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NEUTROPHIL function is regulated in part by cytokines
with growth factor activities for different cell types.
Hepatocyte growth factor (HGF) is a cytokine produced
during injury to the liver and other organs. Neutrophils
are numerous in such tissue injury sites and may be
influenced by HGF. In the present study the effect ofHGF
on neutrophils was investigated. The data show that HGF
at 1-10 ng/ml increased lysosomal enzyme release from
both specific and azurophilic granules of cytochalasin-B
treated neutrophils. The release of specific granule
contents in response to N-formyl-methionyl-leucyl-
phenylalanine was also increased by HGF. In contrast
there were no significant effects of HGF on neutrophil
respiratory burst, adherence or locomotion. It is concluded
that HGF modulates neutrophil granule exocytosis.
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Introduction
Hepatocyte growth factor (HGF) is a potent
mitogen for hepatocytes and is found in the sera of
animals with liver injuries. It is now known that
HGF is a pleiotropic factor (reviewed in References
2 and 3) with effects including promotion of
epithelial cell growth,
2 inhibition of proliferation of
several tumour cell lines,
4 enhancement of epithelial
cell motility and identity with scatter factor and
induction of tubule formation by epithelial cells.
2
The cDNA of HGF has been cloned and the HGF
molecule has been characterized as a heterodimer
consisting of a 65 kDa z chain and a 34 kDa/3 chain,
structurally similar to plasmin.
3 HGF is produced
by Kupffer cells in the liver, and also in other organs
such as lung and kidney, not only in liver injury
but also after renal damage (reviewed in References
2 and 3). The HGF receptor is the c-met
proto-oncogene product, and is widely distributed.
Neutrophil granulocytes are important mediators
of both host defence against microbial attack and
tissue damage by virtue of their armament of
lysosomal granule enzymes and products of the
respiratory burst. The function of mature neu-
trophils can be regulated by cytokines and growth
factors such as interleukin-1 (IL-1),7’8 tumour
necrosis factor-alpha (TNF00,7’9 and granulo-
cyte macrophage colony-stimulating factor (GM-
CSF) 1’11. HGF, like IL-1 and GM-CSF, can be
produced by cells of the monocyte lineage. 12’13
Neutrophil counts are likely to be elevated during
the traumatic injuries which can lead to high HGF
(C) 1993 Rapid Communications of Oxford ktd
production. A form of HGF known as tumour
cytotoxic factor derived from fibroblasts induces
differentiation of HL-60 cells into the mature
granulocyte phenotype.
14 GM-CSF, which pro-
motes the differentiation of granulocyte precursors
also enhances the function of mature granulo-
cytes.1’1’ Therefore HGF was examined for its
effects on neutrophil functions.
Materials and Methods
Hepatocyte growth factor: Human recombinant HGF
was produced in transformed Chinese hamster
ovary cells.
16 A sterile stock solution of HGF at
200 ng/ml in Hank’s balanced salt solution (HBSS)
containing 0.2% bovine serum albumin (BSA;
Commonwealth Serum Laboratories, Melbourne,
Australia) was stored in aliquots at -80C.
Aliquots were thawed once only, and diluted in
HBSS with 0.2% BSA as required for each
experiment. The diluent was sterilizsed by filtration
(0.2/iM) and contained <0.125 endotoxin units/ml
by Limulus lysate assay.
Preparation of neutrophils: Human neutrophils were
isolated from heparinized peripheral blood from
healthy adult volunteers by centrifuging through
Ficoll-Hypaque (density 1.114 g/l) for 30 min.
7
The neutrophils were 98% pure, >99% viable as
judged by trypan blue exclusion, and were used
within 30 min.
Measurements of neutrophil degranulation /-glucuronidase
and vitamin B2 binding protein (Vit 812 BP),
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markers of azurophilic and specific granules,
respectively, were measured as described previous-
ly.
1 Briefly, 106 neutrophils were preincubated for
20 min (unless otherwise stated) at 37C with or
without HGF (0.1-10 ng/ml), and then with or
without cytochalasin-B (2#g/ml final, Sigma)
for 10 min. The cells were then stimulated for
30 min with N-formyl-methionyl-leucyl-phenyl-
alanine (FMLP, Sigma, 5 x 10
-6 M final), or HBSS
control, the volume adjusted to 1 ml with HBSS
and supernatants analysed for enzyme content. In
some experiments phorbol myristate acetate (PMA,
10
-9 or 10
-8 M) or tumour necrosis factor-alpha
(TNF0, 100U/ml) were used as stimuli.
glucuronidase activity was determined by a
modified fluorometric method7’18 and Vit B2 BP
was measured using a radiometric charcoal binding
assay.
9 Results were expressed as a percentage of
total cell content (Triton disrupted cells). Neutro-
phil viability was measured as the release of the
cytoplasmic enzyme lactate dehydrogenase (LDH)
as described previously.
2
Measurement of neutrophil respiratory burst: Neutrophil
chemiluminescence was measured essentially as
described previously using conditions for pre-
incubation with HGF/cytochalasin-B as for de-
granulation assays. The stimuli (FMLP, etc.) or
HBSS control and lucigenin (Sigma, 250M final)
were added to the tubes immediately before placing
them into the luminometer (Model 1250, LKB
Wallac, Turku, Finland). Maximal rate of chemi-
luminescence was recorded as mV. Superoxide
dismutase inhibitable superoxide production was
measured as described previously after preincuba-
tion of neutrophils with HGF as above, and
stimulation with or without FMLP.
Adherence of neutrophils: Neutrophil adherence to
plasma coated plastic microtitre wells was measured
as described
21 using a modified spectrophotometric
assay.
22
Expression of results and statistics: Within each
experiment, assays were conducted in at least
triplicate, using neutrophils from a single donor.
Each experiment was conducted three times or
more with neutrophils from different donors.
Results are presented as means (+_ S.E.M. or range)
of replicate experiments. The significance of the
data was tested using Wilcoxon’s matched pairs
signed ranks test.
Results
Effects of HGF on neutrophil granule exocytosis" HGF
induced the degranulation of neutrophils. Pre-
incubation with recombinant human HGF for
20 min increased the release of both specific and
azurophilic granule components from cytochalasin-
B treated neutrophils in a dose dependent manner
(Fig. 1). HGF concentrations during preincubation
of 1, 5 and 10 ng/ml enhanced the release of Vit B12
BP, a marker of neutrophil specific granules, to
almost double the release from control neutrophils
(Table 1, Fig. 1). The release of/-glucuronidase
(azurophilic granule marker) was also augmented
by HGF at 5 and 10ng/ml (Table 1, Fig. 1).
Although these increases were relatively small
(granule release was less than 10% of the total cell
content, even with HGF stimulus), they were
statistically significant in a group of nine separate
experiments performed with neutrophils from
dierent donors, evaluated with Wilcoxon’s mat-
ched pairs signed ranks test (Fig. 1). The effects of
HGF were observed with incubation times varying
from 10 min to 2 h (results not shown).
The release of Vit B2 BP from cytochalasin-B
treated neutrophils in response to FMLP was also
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FIG. 1. Effect of hepatocyte growth factor on neutrophil granule enzyme
release. Neutrophils were preincubated for 20 min with the indicated
concentrations of HGF, followed by 10 min with cytochalasin-B and then
30 min with 5 x 10-6 M FMLP (lower graph) or without FMLP (upper
graph). The release of vitamin B12 binding protein (open bars) and
fl-glucuronidase (hatched bars) was measured and is expressed as
percentage of total cell content. The mean and S.E.M. of nine experiments
is shown. ,, indicates p < 0.05 for the effect of HGF compared to control
using Wilcoxon’s paired test.
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Table 1. Effect of HGF on neutrophil degranulation, respiratory burst and adherence
HGFd Control
Percent of control value Assay value Number of
Assay Stimulib Mean (range) expts
Vit B12BP cytoB 180 (112-260) 5.3% release 9
cytoB + FMLP 120 (88-184) 41.1% 8
Diluent 113 (77-160) 9.6% 4
FMLP 112 (101-133) 11.5% 3
fl-G ucuron idase cytoB 160 (95-276) 2.0% 8
cytoB + FMLP 103 (72-118) 30.6% 7
Diluent 144 (82-229) 3.9% 3
FMLP 119 (100-157) 4.6% 3
Chemiluminescence cytoB 115 (56-198) 2.1 mV 11
cytoB + FMLP 106 (62-171 159.6 mV 12
Adherence Diluent 136 (32-276) 0.22 ZOD 9
Neutrophils were preincubated with either HGF (10ng/ml) or diluent control for 20min before the
addition of stimuli, b Neutrophils were further treated with various combinations of cytochalasin-B (2/g/ml final) or
diluent for 10 min, followed by FMIP (5 x 10-6M final) or diluent, Assay values for control neutrophils (without HGF)
are shown as mean percent of total cell content released for Vit B12 BP and -glucuronidase, maximal rate of light
emission in mV for chemiluminescence, and change in optical density at 570 nm for adherence, The effect of HGF is
expressed as a percentage of the control assay value (mean and range) for the specified number of experiments.
potentiated by HGF at 5 ng/ml (Fig. 1). Other
concentrations of HGF did not significantly
enhance FMLP elicited Vit B12 BP release, nor was
fl-glucuronidase release significantly increased after
these conditions (Fig. 1, Table 1). HGF did not
affect neutrophil granule enzyme release in
response to PMA or TNF0 (results not shown).
LDH release from neutrophils was not detectable
without FMLP stimulation and was always <7%
with FMLP. LDH release was unaffected by HGF
(results not shown), indicating that HGF did not
impair cell viability or cytosol membrane integrity.
In experiments in which cytochalasin-B was
omitted there was no significant effect on HGF on
either Vit B12 BP or fl-glucuronidase release, nor
was there any consistent or significant effect ofHGF
on FMLP elicited degranulation under these
conditions (Table 1).
Treatment of neutrophils with 100U/ml of
TNF for 30 min is known to prime the cells for
increased enzyme release,
7 and HGF was examined
for its ability to modify this function. Incubation of
neutrophils .with 10 ng/ml HGF immediately after
TNF treatment had no consistent efl:ect on release
of either Vit B2 BP or fl-glucuronidase, with or
without additional FMLP stimulation (results not
shown).
Eect of HGF on neutrophil respiratory burst: Lucigenin
enhanced neutrophil chemiluminescence was used
to measure the respiratory burst. Neutrophils were
preincubated for 20 min with a range of concentra-
tions of HGF, followed by 10 min with cytochala-
sin-B, before monitoring luminescence in response
to FMLP or diluent. HGF at 1 and 10 ng/ml during
preincubation increased basal chemiluminescence
slightly (Table 1) but this increase was not
statistically significant (Wilcoxon’s paired test,
eleven experiments). FMLP induced chemilumin-
escence was not significantly altered by HGF
(Table 1). Increasing HGF concentration to
100 ng/ml during preincubation did not affect either
basal or FMLP stimulated neutrophil chemilumin-
escence (results not shown). There was no eect
of varying the time of preincubation with HGF;
times ranging from 10 min up to 2 h were tested
(results not shown).
In the absence of cytochalasin-B there were no
consistent eects of HGF on neutrophil chemilu-
minescence (results not shown). Chemilumi-
nescence ofTNF primed neutrophils was unaffected
by HGF at concentrations up to 10 ng/ml (four
experiments, results not shown).
Superoxide release from neutrophils was also
measured as superoxide dismutase inhibitable
cytochrome-C reduction. Preincubation of cells for
20 min with 10 ng/ml HGF had no consistent eects
either on basal or FMLP elicited superoxide
responses (97% and 104% of controls without HGF,
respectively).
Effect of HGF on neutrophil adherence: Neutrophil
adhesion to plasma-coated plastic in the presence of
a range of concentrations of HGF was examined in
nine separate experiments using neutrophils from
different donors. There was no consistent effect on
HGF on adherence (Table 1) and responses varied
widely between experiments, with no apparent
dose-response relationship over the concentration
range 0.01-10 ng/ml (results not shown).
Effects ofHGF on neutrophil locomotion: Pretreatment of
neutrophils with 0.01-10 ng/ml of HGF did not
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alter their random migration under agarose, nor oxidase rather than increased respiratory burst
their migration towards the chemotactic agent activity.
FMLP (results not shown). It is unlikely that the increase in granule release
seen with .HGF was due to contamination with
Discussion bacterial endotoxin because there was no effect on
respiratory burst which would be expected with
It is reported here that recombinant human HGF lipopolysaccharide.
28 The recombinant HGF was
induces the release of granule enzymes from prepared in transformed mammalian cells and the
neutrophils. Secretion of both Vit B2 BP and stock solution (200ng/ml) did not contain any
fl-glucuronidase, markers of the specific and measurable TNFfl, TNF or IFN-2 (i.e. <100
azurophilic granules, respectively, was enhanced up pg/ml) by enzyme-linked immunosorbent assay
to 200%, suggesting that HGF is a complete performed in our laboratory. There was also no
secretagogue for human neutrophils. The effect was effect ofHGF on the other neutrophil functions that
dose dependent and required only 10 min pre- were tested. These included adherence to plasma-
incubation. HGF shares this ability to induce the coated plastic and random or chemotactically
exocytosis of both types of neutrophil granule with directed migration under agarose. Taken together
other cytokines e.g. IL-1 v’8 and TNFfl.
23 The these results suggest that HGF is able to induce
magnitude of the increase in enzyme release caused neutrophil granule release without affecting other
by HGF was similar to that observed with TNF,
23 functions.
GM-CSF
1 and interferon gamma (IFN-2),
24 stimu- It is not known if neutrophils express receptors
lation of neutrophils. The increased release of for HGF, but this receptor, known to be the c-met
granule enzymes from HGF treated neutrophils was proto-oncogene product, is widely distributed on
not due to HGF toxicity because viability (LDH many cell types.
6 The high affinity receptor on
release) was not altered, hepatocytes has a Kd of 60-90 pM, corresponding
Neutrophil specific granule release (Vitamin B12 to about 5-8 ng/ml.
2 This study and others which
BP) in response to FMLP/cytochalasin-B was describe effects of HGF on neutrophils
2v and the
increased by HGF at 10 ng/ml only. There was no myeloid cell line HL6014 suggest that neutrophils
effect on /3-glucuronidase release under these might bear HGF receptors.
conditions, nor was there any effect of HGF on Other growth factors can modulate neutrophil
TNF priming of neutrophil exocytosis. These activities. For example growth hormone and
results suggest that HGF does not prime insulin-like growth factor-1 prime neutrophils to
neutrophils for an increased response to subsequent secrete superoxide.
29 Platelet derived growth factor
stimulation in contrast to other cytokines such as upregulates the 5-1ipoxygenase pathway in differ-
TNFo,v’9 IFN-
24’2s or GM-CSF.’11 Cytochalasin-B entiating neutrophils. Transforming growth
was required in these experiments in order for HGF factor-beta induces precursor cells (CFU-GM) to
to exert a measurable effect on basal enzyme release, differentiate preferentially into granulocytes.
31
Cytochalasin-B is a fungal metabolite which Other cytokines which influence cell growth and
interferes with the microtubule contractile system differentiation such as the interleukins and colony-
and phagocytosis.
26 It enhances granule release and stimulating factors, can activate neutrophil func-
respiratory burst in response to otherwise weak or tions including adhesion, migration inhibition,
inactive soluble or particulate agonists.
26 The antibody dependent cytotoxicity, triggering of
release ofneutrophil lysosomal enzymes in response respiratory burst and degranulation, priming for
to IL-1 and TNFo also required cytochalasin-B, v’8 increased responses to stimuli, microbicidal action
The present data show that neutrophil respir- and cartilage damage. 7-11’21-25
atory burst activity was not significantly altered by Since HGF affects differentiation of granulo-
treatment with 0.1-100 ng/ml HGF compared to cytes
14 these findings support the hypothesis that
diluent. These results apparently contrast with a factors which regulate myeloid growth and
recent report that HGF primes neutrophils for differentiation also modulate the function of the
increased luminol enhanced chemiluminescence.
2v mature cell. HGF is produced in several conditions
1-3 We measured lucigenin enhanced chemilumin- such as hepatic failure and renal injury.
escence which is a measure of superoxide release,
28 Neutrophils are likely to encounter high concentra-
the primary oxygen radical produced by neu- tions of HGF at such times. For example serum
trophils. Since chemiluminescence enhanced by HGF concentrations of >1 ng/ml have been
luminol measures formation of other down-stream reported in 82% of patients with fulminant hepatic
reactive oxygen metabolites such as hypochlorous failure, rising to 5-10 ng/ml immediately after
acid which is dependent on myeloperoxidase release plasma exchange.
32 HGF concentrations in the
from the specific granules,
28 the results of Jiang et microenvironment around the HGF-producing
al.
2v may reflect an increased release of myeloper- cells at injury sites are probably even higher.
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Neutrophil precursor cells have also been reported
to produce HGF.
12 It has already been shown that
HGF is a pleiotropic factor with endocrine,
paracrine and autocrine effects on a number of
dierent cell types.
1-3 In this paper it is reported
that HGF at physiological concentrations induces
lysosomal enzyme release from neutrophils. Since
neutrophils are so numerous and have a half-life in
the circulation of only about 7 h, their combined
enzyme release in response to HGF could be
significant. Other cytokines, such as TNFfl,
GM-CSF, TNFo and IFN-2, which increase
neutrophil azurophilic granule release can also
augment neutrophil mediated cartilage damage in
vitro. 21’23 Such host tissue damage is in large part
due to lysosomal enzymes such as elastase.
33 HGF
is likely to be one of many growth factors and
cytokines which contribute to the complex
regulation of immune cell functions.
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